Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
Marsh Sues More Former Employees Over ‘Scheme’ to Open Howden US 
Onex CEO Sees Potential for More Insurance Deals After AIG Win 
China Accuses US of Orchestrating $13 Billion Bitcoin Hack 
Authorities in Miami Investigating Death of Passenger on Cruise Ship 
